EMMANUEL PELAYO: Open Payments
NPI 1770992836 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 7 payments from 6 companies in 2025. Trend: 2023 $16 · 2024 $513 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Eisai Inc. | 1 | $116 |
| Tempus AI, Inc | 2 | $47 |
| Daiichi Sankyo Inc. | 1 | $30 |
| SpringWorks Therapeutics, Inc. | 1 | $14 |
Products named: ZEPBOUND, OPDIVO, Lenvima, XT CDX, Enhertu, OGSIVEO.
Industry payments across NY — which companies pay providers there.
